No, it looks quite bad to me. That revenue provided a lot of research funding, which saved shareholders continual dilutions from capital raisings until their core products got to market and made money. This could hardly have happened at a worse time, with the company running out of cash and the share price very low. I suspect that whatever they do to raise money is going to be very dilutory.
I can't get a break with any speculative stock I've bought. They've all been disasters.
Pezz
any idea, page-3
Add ANX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $15.9M | |||
| Open | High | Low | Value | Volume |
| 2.4¢ | 2.4¢ | 2.3¢ | $2.446K | 105.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 1833551 | 2.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.4¢ | 1139472 | 4 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| ANX (ASX) Chart |